2.42
2.42 (0%)
As of Feb 14, 2025
Neuraxis, INC [NRXS]
Source:
Company Overview
Neuraxis, Inc is a medical technology company focusedon developing neuromodulation therapies to address chronic and debilitating conditions in children and adults.
| Country | United States |
| Headquarters | |
| Phone Number | |
| Industry | |
| CEO | Brian Carrico |
| Website | neuraxis.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $2.7 |
| Operating Profit | $-7.2 |
| Net Income | $-8.2 |
| Net Cash | $3.6 |
Profit Ratios
| Gross Margin | $2.3 |
| Operating Margin | -266.5 |
| Profit as % of Revenues | -28.2% |
| Profit as % of Assets | -312.9% |
| Profit as % of Stockholder Equity | -398.6% |
Management Effectiveness
| Return on Equity | -398.6% |
| Return on Assets | -173.2% |
| Turnover Ratio | 102% |
| EBITA | $-7.2 |
Balance Sheet and Cash Flow Measures
| Total Assets | $4.8 |
| Total Liabilities | $2.7 |
| Operating Cash Flow | $-6.1 |
| Investing Cash Flow | $-0 |
| Financing Cash Flow | $9.7 |
